Skip to main content
TipRanks
Go Ultimate75% OFF

Kontafarma China Holdings Ltd (1312) Financial Statements

0 Followers

Kontafarma China Holdings Ltd Financial Overview

Kontafarma China Holdings Ltd's market cap is currently HK$150.63M. The company's EPS TTM is HK$-0.04; its P/E ratio is -0.71; and it has a dividend yield of 2.96%. Kontafarma China Holdings Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueHK$ 914.71MHK$ 897.52MHK$ 809.11MHK$ 894.06MHK$ 803.27M
Gross ProfitHK$ 513.64MHK$ 516.16MHK$ 471.29MHK$ 506.22MHK$ 396.18M
Operating IncomeHK$ -242.83MHK$ -42.51MHK$ -164.30MHK$ -137.29MHK$ -119.91M
EBITDAHK$ -151.75MHK$ 6.71MHK$ 78.50MHK$ 36.29MHK$ 25.23M
Net IncomeHK$ -427.85MHK$ -75.54MHK$ -28.84MHK$ -41.55MHK$ -15.05M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 66.06MHK$ 90.58MHK$ 87.66MHK$ 142.59MHK$ 183.96M
Total AssetsHK$ 1.07BHK$ 1.59BHK$ 1.73BHK$ 2.12BHK$ 2.56B
Total DebtHK$ 203.68MHK$ 297.19MHK$ 333.82MHK$ 590.72MHK$ 728.95M
Net DebtHK$ 137.62MHK$ 216.60MHK$ 256.16MHK$ 468.13MHK$ 560.99M
Total LiabilitiesHK$ 588.92MHK$ 625.90MHK$ 665.39MHK$ 964.16MHK$ 1.22B
Stockholders' EquityHK$ 553.26MHK$ 978.70MHK$ 1.06BHK$ 1.10BHK$ 1.19B
Cash Flow
Free Cash FlowHK$ 53.15MHK$ 33.41MHK$ 12.92MHK$ -53.84MHK$ -49.31M
Operating Cash FlowHK$ 76.68MHK$ 47.05MHK$ 37.12MHK$ -2.17MHK$ 75.07M
Investing Cash FlowHK$ 8.82MHK$ -6.01MHK$ 144.14MHK$ 121.53MHK$ 23.24M
Financing Cash FlowHK$ -90.16MHK$ -42.52MHK$ -198.81MHK$ -137.33MHK$ -99.80M

Currency in HKD

Kontafarma China Holdings Ltd Earnings and Revenue History

-1.2B01.2B2.4B-50 %-25 %0 %25 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Kontafarma China Holdings Ltd Liabilities to Assets

01.5B3B4.5B30 %40 %50 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Kontafarma China Holdings Ltd Cash Flow

-400M-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing

Kontafarma China Holdings Ltd Forecast EPS vs Actual EPS

-0.10000Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss